These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7273379)

  • 61. Pathophysiology of chronic cyanosis in a canine model. Functional and metabolic response to global ischemia.
    Lupinetti FM; Wareing TH; Huddleston CB; Collins JC; Boucek RJ; Bender HW; Hammon JW
    J Thorac Cardiovasc Surg; 1985 Aug; 90(2):291-6. PubMed ID: 4021530
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hemodynamic aspects of the treatment of ischemic heart disease.
    Wellens D
    Angiology; 1977 Dec; 28(12):839-43. PubMed ID: 23714
    [No Abstract]   [Full Text] [Related]  

  • 63. The cardioprotective effects of R 75231 and lidoflazine are not caused by adenosine A1 receptor activation.
    Grover GJ; Sleph PG
    J Pharmacol Exp Ther; 1994 Jan; 268(1):90-6. PubMed ID: 8301599
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Protection of human, rat, and guinea-pig atrial muscle by mioflazine, lidoflazine, and verapamil against the destructive effects of high concentrations of Ca2+.
    Ravens U; Liu GS; Vandeplassche G; Borgers M
    Cardiovasc Drugs Ther; 1992 Feb; 6(1):47-58. PubMed ID: 1576096
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Calcium blockers in cerebral resuscitation.
    White BC; Winegar CD; Wilson RF; Krause GS
    J Trauma; 1983 Sep; 23(9):788-94. PubMed ID: 6620432
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of global ischemia on the diastolic properties of the left ventricle in the conscious dog.
    Visner MS; Arentzen CE; Parrish DG; Larson EV; O'Connor MJ; Crumbley AJ; Bache RJ; Anderson RW
    Circulation; 1985 Mar; 71(3):610-9. PubMed ID: 3156009
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Lidoflazine and physical training in the treatment of stable angina pectoris.
    Ferguson RJ; Côté P; Bourassa MG; Corbara F
    Clin Cardiol; 1979 Dec; 2(6):413-6. PubMed ID: 397017
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The effect of lidoflazine on exercise tolerance in patients with angina pectoris.
    Nordstrom LA; Globel FL
    Chest; 1978 Jul; 74(1):50-4. PubMed ID: 352634
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Acute effects of furosemide on blood electrolytes and hemodynamics in dogs.
    Koob R; Prasad K
    Angiology; 1978 Jun; 29(6):463-72. PubMed ID: 686480
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The efficacy of blood versus crystalloid coronary sinus cardioplegia during global myocardial ischemia.
    Goldstein JP; Salter DR; Murphy CE; Abd-Elfattah AS; Morris JJ; Wechsler AS
    Circulation; 1986 Nov; 74(5 Pt 2):III99-104. PubMed ID: 3769191
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The effect of carbon dioxide, lidoflazine and deferoxamine upon long term survival following cardiorespiratory arrest in rats.
    Badylak SF; Babbs CF
    Resuscitation; 1986 Apr; 13(3):165-73. PubMed ID: 3012732
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A quantitative morphological assessment of the effect of lidoflazine and deferoxamine therapy on global brain ischaemia.
    Kumar K; White BC; Krause GS; Indrieri RJ; Evans AT; Hoehner TJ; Garritano AM; Koestner A
    Neurol Res; 1988 Sep; 10(3):136-40. PubMed ID: 2905775
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The effect of intravenous lidoflazine on whole blood-induced basilar artery contraction. An in vivo study.
    Rosenwasser RH; Tuma RF; Buchheit WA; McDowell A
    Surg Neurol; 1987 Jun; 27(6):533-6. PubMed ID: 3576428
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Intensive albumin therapy and pressure modifications during acute coronary ischemia in the dog].
    Mbuyamba PW
    Arch Int Physiol Biochim; 1976 Dec; 84(5):1017-26. PubMed ID: 65980
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Studies on the possible mechanisms of lidoflazine arrhythmogenicity.
    Keren G; Tepper D; Butler B; Maguire W; Willens H; Miura D; Somberg JC
    J Am Coll Cardiol; 1984 Oct; 4(4):742-7. PubMed ID: 6481014
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A randomized clinical study of a calcium-entry blocker (lidoflazine) in the treatment of comatose survivors of cardiac arrest.
    Brain Resuscitation Clinical Trial II Study Group
    N Engl J Med; 1991 May; 324(18):1225-31. PubMed ID: 2014035
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A randomized clinical trial of calcium entry blocker administration to comatose survivors of cardiac arrest. Design, methods, and patient characteristics. The Brain Resuscitation Clinical Trial II Study Group.
    Control Clin Trials; 1991 Aug; 12(4):525-45. PubMed ID: 1657528
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The ultrastructure of human livers after prolonged lidoflazine therapy.
    Verheyen A; Borgers M; Blaton H; Sowa H
    Toxicol Appl Pharmacol; 1975 Nov; 34(2):224-32. PubMed ID: 1209621
    [No Abstract]   [Full Text] [Related]  

  • 79. Effects of lidoflazine and mioflazine against potassium and veratrine induced shape changes in isolated rat cardiac myocytes.
    Ver Donck L; Liu GS; Vandeplassche G; Borgers M
    Basic Res Cardiol; 1987; 82(1):74-81. PubMed ID: 3593184
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Liver ultrastructure of dogs treated with lidoflazine for 4 years.
    Borgers M; Verheyen A; Marsboom R
    Toxicol Appl Pharmacol; 1975 Aug; 33(2):376-9. PubMed ID: 1179440
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.